These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 27851755)

  • 1. Pretreatment Hematocrit Is Superior to Hemoglobin as a Prognostic Factor for Triple Negative Breast Cancer.
    Chen B; Dai D; Tang H; Ai X; Chen X; Zhang X; Li Z; Xie X
    PLoS One; 2016; 11(11):e0165133. PubMed ID: 27851755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Peripheral Blood Neutrophil-To-Lymphocyte Ratio Is Superior to the Lymphocyte-To-Monocyte Ratio for Predicting the Long-Term Survival of Triple-Negative Breast Cancer Patients.
    Jia W; Wu J; Jia H; Yang Y; Zhang X; Chen K; Su F
    PLoS One; 2015; 10(11):e0143061. PubMed ID: 26580962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-treatment anemia is a poor prognostic factor in soft tissue sarcoma patients.
    Szkandera J; Gerger A; Liegl-Atzwanger B; Stotz M; Samonigg H; Ploner F; Stojakovic T; Leithner A; Pichler M
    PLoS One; 2014; 9(9):e107297. PubMed ID: 25207808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of survivin and EGFR protein expression in triple-negative breast cancer (TNBC) patients.
    Zhang M; Zhang X; Zhao S; Wang Y; Di W; Zhao G; Yang M; Zhang Q
    Target Oncol; 2014 Dec; 9(4):349-57. PubMed ID: 24233638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative low hematocrit is an adverse prognostic biomarker in ovarian cancer.
    Chen J; Li Y; Cui H
    Arch Gynecol Obstet; 2021 Mar; 303(3):767-775. PubMed ID: 33011886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting the role of the pretreatment neutrophil to lymphocyte ratio in the survival of early triple-negative breast cancer patients.
    Bozkurt O; Karaca H; Berk V; Inanc M; Ocak Duran A; Ozaslan E; Ucar M; Ozkan M
    J BUON; 2015; 20(6):1432-9. PubMed ID: 26854438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment lymphocyte to monocyte ratio as a predictor of prognosis in patients with early-stage triple-negative breast cancer.
    He J; Lv P; Yang X; Chen Y; Liu C; Qiu X
    Tumour Biol; 2016 Jul; 37(7):9037-43. PubMed ID: 26762408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous fall in hemoglobin level is a poor prognostic factor in patients with nasopharyngeal carcinoma treated with radiotherapy.
    Gao J; Hu JY; Xia YF; Yi W; Tao YL; Li G
    Chin J Cancer; 2010 May; 29(5):561-6. PubMed ID: 20426909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stratification of Prognosis of Triple-Negative Breast Cancer Patients Using Combinatorial Biomarkers.
    Yue Y; Astvatsaturyan K; Cui X; Zhang X; Fraass B; Bose S
    PLoS One; 2016; 11(3):e0149661. PubMed ID: 26930401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of preoperative anemia on relapse and survival in breast cancer patients.
    Zhang Y; Chen Y; Chen D; Jiang Y; Huang W; Ouyang H; Xing W; Zeng M; Xie X; Zeng W
    BMC Cancer; 2014 Nov; 14():844. PubMed ID: 25406979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of tumor-infiltrating lymphocytes in patients with early-stage triple-negative breast cancers (TNBC) who did not receive adjuvant chemotherapy.
    Park JH; Jonas SF; Bataillon G; Criscitiello C; Salgado R; Loi S; Viale G; Lee HJ; Dieci MV; Kim SB; Vincent-Salomon A; Curigliano G; André F; Michiels S
    Ann Oncol; 2019 Dec; 30(12):1941-1949. PubMed ID: 31566659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ratio of hemoglobin to red cell distribution width as a novel prognostic parameter in esophageal squamous cell carcinoma: a retrospective study from southern China.
    Sun P; Zhang F; Chen C; Bi X; Yang H; An X; Wang F; Jiang W
    Oncotarget; 2016 Jul; 7(27):42650-42660. PubMed ID: 27223088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of Ki-67 according to age in patients with triple-negative breast cancer.
    Zenzola V; Cabezas-Quintario MA; Arguelles M; Pérez-Fernández E; Izarzugaza Y; Correa A; García-Foncillas J
    Clin Transl Oncol; 2018 Nov; 20(11):1448-1454. PubMed ID: 29671222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral oxygen transport failure?: decreasing hemoglobin and hematocrit levels after ischemic stroke predict poor outcome and mortality: STroke: RelevAnt Impact of hemoGlobin, Hematocrit and Transfusion (STRAIGHT)--an observational study.
    Kellert L; Martin E; Sykora M; Bauer H; Gussmann P; Diedler J; Herweh C; Ringleb PA; Hacke W; Steiner T; Bösel J
    Stroke; 2011 Oct; 42(10):2832-7. PubMed ID: 21852622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant chemotherapy-induced hemoglobin decline as a prognostic factor in osteosarcoma around the knee joint: a single-center retrospective analysis of 242 patients.
    Yu W; Sun M; Wang W; Shen Z; Wang Y; Li H
    Support Care Cancer; 2024 Jun; 32(7):415. PubMed ID: 38847977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nomograms for Predicting the Prognostic Value of Pre-Therapeutic CA15-3 and CEA Serum Levels in TNBC Patients.
    Dai D; Chen B; Tang H; Wang B; Zhao Z; Xie X; Wei W
    PLoS One; 2016; 11(8):e0161902. PubMed ID: 27561099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of nomograms predicting survival in Chinese patients with triple negative breast cancer.
    Yang Y; Wang Y; Deng H; Tan C; Li Q; He Z; Wei W; Zhou E; Liu Q; Liu J
    BMC Cancer; 2019 Jun; 19(1):541. PubMed ID: 31170946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term treatment efficacy in primary inflammatory breast cancer by hormonal receptor- and HER2-defined subtypes.
    Masuda H; Brewer TM; Liu DD; Iwamoto T; Shen Y; Hsu L; Willey JS; Gonzalez-Angulo AM; Chavez-MacGregor M; Fouad TM; Woodward WA; Reuben JM; Valero V; Alvarez RH; Hortobagyi GN; Ueno NT
    Ann Oncol; 2014 Feb; 25(2):384-91. PubMed ID: 24351399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of outcomes between metaplastic and triple-negative breast cancer patients.
    Polamraju P; Haque W; Cao K; Verma V; Schwartz M; Klimberg VS; Hatch S; Niravath P; Butler EB; Teh BS
    Breast; 2020 Feb; 49():8-16. PubMed ID: 31675684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive and prognostic effect of HO-1 expression in breast cancer patients undergoing neoadjuvant chemotherapy.
    Tan Q; Qin Q; Huang Z; Lian B; Mo Q; Wei C
    Breast Cancer Res Treat; 2022 Jun; 193(2):393-403. PubMed ID: 35304903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.